LGND
Ligand Pharmaceuticals Incorporated
$189.55
+$6.42(+3.51%)
55
Overall
40
Value
58
Tech
68
Quality
Market Cap
$3.56B
Volume
284.90K
52W Range
$93.58 - $212.49
Target Price
$225.00
EPS Estimates Overview
| Current Quarter | $0.63 | Next Quarter | $0.62 |
| Current Year | $-0.51 | Next Year | $4.67 |
| QoQ Growth | -1.6% | YoY Growth | +1015.7% |
| 3Y EPS CAGR | -28.1% | Target Price | $225.00 |
| Consensus | Buy | Upside | +18.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $189.55 | +3.5% | 284.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW